News Center

Events

Other Event

Bioethics Genius Prize

April 27, 2018May 4, 2018

BEI’s Inaugural
Bioethics Genius Prize
Apply by April 27, 2018

 

We are looking to support and recognize a bioethics innovator—a person or team who are not just thinking about how to improve ethics and patient centricity in healthcare innovation, but who are also making it happen. Are you working to raise the bar and operationalize bioethics in healthcare innovation?  If so, apply by April 27th, for our inaugural Bioethics Genius Prize.

More

Other Event

Forum: Bioethics, Patient-Centricity & Pharma

May 4, 2018 8:30am-2:30pm

In partnership with Ernst & Young and Scientific American, Bioethics International is hosting a Forum on what it means to be a purpose driven, patient-centered and ethical pharma and health-innovation company. 

Location: New York, NY

More

All Events

Blog

New York Times interviews our founder, Jennifer Miller, on FDA's clinical trial transparency pilot

The New York Times interviewed our founder, Jennifer Miller, on FDA Commissioner Dr. Scott Gottlieb's clinical trial transparency initiatives. She discussed his new pilot, launched last month, which selects 9 recently-approved drugs, whose sponsors (generally pharmaceutical companies) volunteer to participate, to post portions of Clinical Study Reports (CSRs) from their pivotal trials on FDA's website…

February 12, 2018

Big Data Probably Knows More About You Than Your Friends Do

This week we focused on the ethics of Big Data, publishing an article titled, Big Data Probably Knows More About You Than Your Friends Do, in Leaps Mag. The article discusses the promises and perils of big data and concludes with a way to manage your data wealth.  To read the full article click here.

February 7, 2018

All Posts

Publications

Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies

Miller JE, Wilenzick M, Ritcey N, et al. Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies. BMJ Open 2017;0:e017917. doi:10.1136/ bmjopen-2017-017917

Cross-sectional descriptive analysis of all clinical trials supporting 2014 Food and Drugs Administration (FDA)-approved new drug applications (NDAs) for novel drugs sponsored by large companies.

How full disclosure of clinical trial data will benefit the pharmaceutical industry

Miller JE (2016). The Pharmaceutical JournalDOI: 10.1211/PJ.2016.20201274

Disclosing clinical trial data is a step in the right direction towards transparency, which benefits both the public and the pharmaceutical industry.

All Publications

Press and Media Inquires

All press and media inquiries should be directed to:

Maggie Beller, Russo Partners LLC
maggie.beller@russopartnersllc.com
646-942-5631

Naomi Bowen, Behrman Communications
bioethics@behrmanpr.com
212-986-7000 ext. 119

Newsletter